Sign in to continue:

Wednesday, March 11th, 2026

Greenlight Capital Re 2025 Annual Report: Business Segments, Financial Performance, and Insurance Contract Details

Greenlight Capital Re, Ltd. 2025 Annual Report: Key Highlights for Investors

Greenlight Capital Re, Ltd. has released its 2025 Annual Report (10-K), providing shareholders and potential investors with a comprehensive view into the company’s financial position, business operations, and segmental performance. The following is a detailed review of the most relevant and potentially price-sensitive information disclosed in the filing.

Key Highlights from the Report

  • Business Overview:
    • Greenlight Capital Re, Ltd. is a specialist reinsurance company, domiciled in the Cayman Islands, with its primary business in fire, marine, and casualty insurance.
    • The company’s operations are organized by business segments, mainly: Open Market and Innovations.
  • Segmental Performance and Financial Position:
    • The report details operating results differentiated by business segments—Open Market, Innovations, and Corporate Non-segment.
    • The company tracks performance by product/service lines: Financial, Health, Multiline, Property, Specialty, and Casualty, with additional granularity by accident years (2016–2025).
    • Investors should note the recurring references to “Favorable” and “Adverse Reserve Development” in reinsurance contracts—these items can significantly impact earnings and capital reserves.
  • Investment Portfolio and Asset Allocation:
    • Greenlight Capital Re’s investment portfolio is diversified with allocations in:
      • US Government Agency Debt Securities
      • Residential and Non-Agency Mortgage-Backed Securities
      • Corporate Bonds
      • Asset-Backed Securities
      • Municipal Bonds
      • Private Equity Funds
      • Private Convertible Debt Securities
      • Other Private Investments & Unlisted Equity Securities
    • The company uses fair value measurements (Levels 1, 2, and 3), with recurring and nonrecurring valuation adjustments. Changes in the valuation of these assets can directly affect the company’s book value and earnings.
  • Cash and Liquidity Management:
    • Greenlight Capital Re manages cash across various categories, including:
      • Cash Collateral for Letters of Credit
      • Cash Securing Loan Facilities
      • Other Cash and Cash Equivalents
    • Restricted cash balances and collateralization are important for understanding the company’s liquidity profile and its ability to underwrite additional business or return capital to shareholders.
  • Equity Method Investments:
    • The company holds significant equity method investments, notably in Solasglas Investments LP and related entities, which are referenced throughout the filing.
    • These investments can impact reported earnings and book value, depending on their performance each year.
  • Segmental Reserve Developments:
    • The report distinguishes reserve development on a segmental and accident year basis, with explicit tracking of both favorable and adverse development. This is a key driver of profitability for reinsurance companies.
    • Investors should be alert to any material changes in reserve estimates, as these can lead to significant earnings swings and impact capital adequacy.

Important Considerations for Shareholders

  • Potentially Price-Sensitive Elements:
    • Reserve Development: Shifts in reserve estimates (either favorable or adverse) can have an immediate and significant effect on quarterly and annual results.
    • Asset Valuation Adjustments: The fair value hierarchy and periodic valuation adjustments (especially for Level 3 assets and private investments) may introduce volatility to reported results and could surprise the market.
    • Liquidity and Collateralization: Levels of restricted cash and collateral requirements affect the company’s flexibility in capital management and its ability to respond to new opportunities or challenges.
    • Segmental and Product Line Results: Trends by business segment or product line (e.g., Health, Property, Multiline, Casualty, Specialty, Financial) may indicate where the company is seeing growth or encountering challenges.
    • Equity Method Investments Performance: Performance of Solasglas Investments LP and similar entities can impact both reported income and balance sheet strength.

Conclusion: What Could Move the Share Price?

While the 2025 Annual Report provides extensive details on Greenlight Capital Re’s business segmentation, investment allocation, and reserve development, the most price-sensitive factors for shareholders are:

  • Any unexpected adverse reserve development in accident years, especially in core segments like Open Market and Innovations.
  • Material changes in the valuation of investment assets, particularly Level 3/private investments, which could affect book value.
  • Trends in liquidity and collateral usage, which may signal shifts in risk profile or capital flexibility.
  • Performance of significant equity method investments, which could swing net earnings and capital position.

Shareholders should review the footnotes and segment disclosures for any material changes in these areas, as they are likely to be scrutinized by analysts and could drive share price volatility following the release of results.


Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should review the full 10-K filing and consult with their financial advisor before making any investment decisions. Past performance is not indicative of future results.

View GREENLIGHT CAPITAL RE, LTD. Historical chart here



ALX Oncology 2025 Annual Report: Evorpacept Clinical Trials, Pipeline Strategy, and CD47 Blockade Advancements

ALXO 10-K Key Investor Highlights ALXO Oncology 2025 Ann...

FIRST FINANCIAL CORP /IN/ 2025 Annual 10-K Report: Financial Performance, Loan Portfolio, and Asset Details

First Financial Corporation 2025 10-K: Key Updates for Inves...

   Ad